|Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates|
Y Simoni, E Becht, M Fehlings, CY Loh, SL Koo, KWW Teng, JPS Yeong, ...
Nature 557 (7706), 575-579, 2018
|Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma|
M Garnelo, A Tan, Z Her, J Yeong, CJ Lim, J Chen, KH Lim, A Weber, ...
Gut 66 (2), 342-351, 2017
|Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy|
WCC Tan, SN Nerurkar, HY Cai, HHM Ng, D Wu, YTF Wee, JCT Lim, ...
Cancer Communications 40 (4), 135-153, 2020
|Genomic landscape of lung adenocarcinoma in East Asians|
J Chen, H Yang, ASM Teo, LB Amer, FG Sherbaf, CQ Tan, JJS Alvarez, ...
Nature genetics 52 (2), 177-186, 2020
|Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma|
CJ Lim, YH Lee, L Pan, L Lai, C Chua, M Wasser, TKH Lim, J Yeong, ...
Gut 68 (5), 916-927, 2019
|PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity|
TS Lim, V Chew, JL Sieow, S Goh, JPS Yeong, AL Soon, ...
Oncoimmunology 5 (3), e1085146, 2016
|Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer|
H Matsumoto, AA Thike, H Li, J Yeong, S Koo, RA Dent, PH Tan, J Iqbal
Breast cancer research and treatment 156, 237-247, 2016
|Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancer|
J Yeong, AA Thike, JCT Lim, B Lee, H Li, SC Wong, SSS Hue, PH Tan, ...
Breast cancer research and treatment 163, 21-35, 2017
|High densities of tumor-associated plasma cells predict improved prognosis in triple negative breast cancer|
J Yeong, JCT Lim, B Lee, H Li, N Chia, CCH Ong, WK Lye, TC Putti, ...
Frontiers in immunology 9, 1209, 2018
|Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19|
CCL Cheung, D Goh, X Lim, TZ Tien, JCT Lim, JN Lee, B Tan, ZEA Tay, ...
Gut 71 (1), 226-229, 2022
|Prognostic value of CD8+ PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer|
J Yeong, JCT Lim, B Lee, H Li, CCH Ong, AA Thike, WH Yeap, Y Yang, ...
Journal for immunotherapy of cancer 7, 1-13, 2019
|Activation and regulation of interferon-β in immune responses|
WX Sin, P Li, JPS Yeong, KC Chin
Immunologic research 53, 25-40, 2012
|An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use|
JCT Lim, JPS Yeong, CJ Lim, CCH Ong, SC Wong, VSP Chew, ...
Pathology 50 (3), 333-341, 2018
|Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma|
JY Chan, JQ Lim, J Yeong, V Ravi, P Guan, A Boot, TKY Tay, ...
The Journal of clinical investigation 130 (11), 5833-5846, 2020
|Multiplex immunohistochemistry/immunofluorescence (mIHC/IF) for PD-L1 testing in triple-negative breast cancer: a translational assay compared with conventional IHC|
J Yeong, T Tan, ZL Chow, Q Cheng, B Lee, A Seet, JX Lim, JCT Lim, ...
Journal of Clinical Pathology 73 (9), 557-562, 2020
|Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma|
HHM Ng, RY Lee, S Goh, ISY Tay, X Lim, B Lee, V Chew, H Li, B Tan, ...
Journal for immunotherapy of cancer 8 (2), 2020
|Pan-cancer analysis connects tumor matrisome to immune response|
SB Lim, MLK Chua, JPS Yeong, SJ Tan, WT Lim, CT Lim
NPJ precision oncology 3 (1), 15, 2019
|Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma|
Y Cheng, B Gunasegaran, HD Singh, CA Dutertre, CY Loh, JQ Lim, ...
Immunity 54 (8), 1825-1840. e7, 2021
|Expression of CD38 on macrophages predicts improved prognosis in hepatocellular carcinoma|
JH Lam, HHM Ng, CJ Lim, XN Sim, F Malavasi, H Li, JJH Loh, K Sabai, ...
Frontiers in immunology, 2093, 2019
|Identifying progression predictors of breast ductal carcinoma in situ|
J Yeong, AA Thike, PH Tan, J Iqbal
Journal of Clinical Pathology 70 (2), 102-108, 2017